$71.00
The 10mg extended format of OVA’s gut and skin anti-inflammatory tripeptide — for women running full 8-week KPV protocols for IBD, cyclical gut inflammation, or hormonal skin conditions.
3-5 business days
SSL encrypted
KPV at 10mg supports a complete 8-week protocol at standard doses for gut-targeted use. At this scale, the progressive anti-inflammatory effects of KPV can run their full course: mucosal healing in inflammatory bowel conditions typically shows measurable improvement at 4 weeks and continued progress through 8–12 weeks of consistent use. The 10mg format is also the practical choice for women using KPV topically (dissolved in a carrier) alongside internal administration for concurrent gut-skin protocols.
KPV’s MC1R-mediated anti-inflammatory mechanism makes it complementary to VIP (which addresses neuroimmune inflammation) and BPC-157 (which provides the repair and angiogenesis layer). For women with complex inflammatory patterns — gut inflammation driving skin flares, or vice versa — a layered approach combining KPV, BPC-157, and VIP addresses the inflammatory cascade at multiple points.
Female-calibrated dosing: 250–500mcg orally 2x/day or subcutaneously daily for gut use. 250–500mcg subcutaneously near inflamed skin areas for dermatological use. The 10mg vial supports 4–8 weeks at standard doses.
Storage: Store lyophilized powder below -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
| Dosage | 10mg |
|---|---|
| Format | Injectable Vial |
| Cycle Length | 8–12 weeks |
| Storage | Freeze until use. Refrigerate after reconstitution. Use within 30 days. |
Reviews
There are no reviews yet.